Researchers use genomics to classify reasons for diabetic retinopathy

Researchers use genomics to classify reasons for diabetic retinopathy

The University of Illinois Researchers in Chicago have also established a new method to study other disorders, to investigate the genetic mechanisms behind diabetic retinopathy.

Researchers have identified genes that respond differently to high glucose reactions in individuals with and without diabetes retinopathy, published on eLife, “Integration of genomics and transcriptomics predicts diabetic retinopathy susceptibility genes,”

Dr. Grassi, UIC College of Medicine associate professor of ophthalmology, and Dr. Barbara Stranger, of NW University, his collaborators are focusing on genes that cause diabetes retinopathy, which is a diabetes-related condition of the light-sensitive back of the eye — the retina — resulting in a loss of vision.

Since he started his professional training as a retina specialist, Grassi has been involved in diabetic retinopathy.

“I met a 19-year-old with 5-year-old well-regulated diabetes who was blind, and a veteran of Vietnam, who had poor diabetes management for over 30 years, yet had no visionary concerns,” Grassi said. “I noticed two people with opposite results.

Grassi’s genetic basis for diabetic retinopathy has been investigated for 10 years. He eventually ended up using a tool after many attempts that led to the discovery of genes that raise the likelihood of retinopathy forming.

Grassi and his team have integrated various gene recognition strategies, such as folliculin or FLCN, which raise the likelihood of retinopathy. They started by comparing the levels of gene activation with and without retinopathy in individuals. A variety of genes were identified, which were unique to retinopathists.

Next they took for this gene set the genetic marker and found many to be associated with diabetic retinopathy growth. Finally, they checked whether differences in certain gene levels could result in retinopathy and found that increased FLCN concentrations raise the risk of retinopathy.

In the cell lines of people with type 1 diabetes, both with and without retinopathy, glucose-induced improvements were investigated by the investigative team. This approach brought new insights into the disease. In addition to validations in separate cohorts, single nucleotide polymorphisms (SNPs) were calculated in relation to certain changes—eQtls. The approach was further improved by the FLCN as a mediator of diabetic retinopathy using Mendelian Randomisation.

“It has been a challenge to study diabetic retinopathy because it is so heterogeneous. There are so many genetic factors that can contribute,” Grassi said.

Cell lines produced by blood samples were used from a major clinical trial of diabetic retinopathy called Diabetes Control and Complications Test, or DCCT. Since cell lines were produced for each individual in the DCCT sample, the retinopathic gravity of individuals was detailedly defined.

Comprehension of genetic causes underlying DR will eventually contribute to the advancement of alternative retinopathy treatment and prevention strategies. The latest treatment standard requires laser surgery to protect the middle of the vision or eye injections every four weeks.

Researchers use genomics to classify reasons for diabetic retinopathy

Rajat Singh
Rajat Singh is the chief Author at Bioinformatics India, he has been writing for the past 3 years and has a special interest in SEO, Technology, Health, Life Sciences and gaming.

Get in Touch

Related Articles

Get in Touch

Get new posts by email:

Latest Posts